DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,979,801 | -10.6% | 149,052 | -13.5% | 0.59% | -5.6% |
| Q2 2023 | $41,358,720 | -5.7% | 172,328 | -1.0% | 0.63% | -10.5% |
| Q1 2023 | $43,881,425 | +93108.1% | 174,105 | -1.8% | 0.70% | -5.6% |
| Q4 2022 | $47,079 | -99.9% | 177,375 | -0.0% | 0.74% | -3.8% |
| Q3 2022 | $45,835,000 | +2.3% | 177,452 | +0.4% | 0.77% | +10.9% |
| Q2 2022 | $44,791,000 | -13.7% | 176,679 | -0.2% | 0.70% | +1.5% |
| Q1 2022 | $51,914,000 | -9.0% | 176,984 | +2.1% | 0.69% | -4.6% |
| Q4 2021 | $57,025,000 | +75.9% | 173,322 | +62.8% | 0.72% | -1.2% |
| Q3 2021 | $32,417,000 | +16.0% | 106,482 | +2.3% | 0.73% | +13.9% |
| Q2 2021 | $27,945,000 | +18.7% | 104,131 | -0.4% | 0.64% | +11.3% |
| Q1 2021 | $23,538,000 | +3.8% | 104,575 | +2.4% | 0.58% | -5.9% |
| Q4 2020 | $22,686,000 | +40.8% | 102,126 | +12.0% | 0.61% | +22.2% |
| Q3 2020 | $16,117,000 | 0.0% | 91,144 | 0.0% | 0.50% | 0.0% |
| Q2 2020 | $16,117,000 | +26.5% | 91,144 | -1.0% | 0.50% | +9.6% |
| Q1 2020 | $12,740,000 | -7.3% | 92,043 | +2.8% | 0.46% | +20.3% |
| Q4 2019 | $13,743,000 | +5.3% | 89,542 | -0.9% | 0.38% | +20.7% |
| Q3 2019 | $13,055,000 | +53.4% | 90,387 | +51.7% | 0.31% | +50.2% |
| Q2 2019 | $8,513,000 | +9.3% | 59,567 | +1.0% | 0.21% | -11.8% |
| Q1 2019 | $7,786,000 | +19.7% | 58,974 | -6.5% | 0.24% | +19.1% |
| Q4 2018 | $6,505,000 | -5.7% | 63,091 | -0.6% | 0.20% | -2.9% |
| Q3 2018 | $6,898,000 | +10.3% | 63,479 | +0.2% | 0.20% | +3.5% |
| Q2 2018 | $6,252,000 | -6.8% | 63,359 | -7.5% | 0.20% | -8.8% |
| Q1 2018 | $6,707,000 | +0.5% | 68,496 | -4.7% | 0.22% | -0.5% |
| Q4 2017 | $6,673,000 | +15.2% | 71,888 | +6.5% | 0.22% | +9.5% |
| Q3 2017 | $5,791,000 | +2.0% | 67,509 | +0.3% | 0.20% | 0.0% |
| Q2 2017 | $5,679,000 | -6.8% | 67,298 | -5.6% | 0.20% | -6.6% |
| Q1 2017 | $6,096,000 | -4.1% | 71,284 | -12.7% | 0.21% | -9.0% |
| Q4 2016 | $6,355,000 | +7.3% | 81,642 | +8.1% | 0.23% | -2.1% |
| Q3 2016 | $5,921,000 | -32.3% | 75,535 | -12.8% | 0.24% | -35.1% |
| Q2 2016 | $8,749,000 | -1.5% | 86,626 | -7.5% | 0.37% | -2.9% |
| Q1 2016 | $8,886,000 | -8.6% | 93,682 | -10.5% | 0.38% | -10.4% |
| Q4 2015 | $9,723,000 | +10.0% | 104,686 | +1.0% | 0.42% | -18.5% |
| Q3 2015 | $8,836,000 | -2.6% | 103,696 | -2.1% | 0.52% | +25.1% |
| Q2 2015 | $9,068,000 | -8.4% | 105,938 | -9.2% | 0.42% | -7.0% |
| Q1 2015 | $9,902,000 | -2.3% | 116,632 | -1.3% | 0.45% | -1.5% |
| Q4 2014 | $10,131,000 | +10.3% | 118,204 | -2.2% | 0.45% | +1.1% |
| Q3 2014 | $9,186,000 | -6.7% | 120,898 | -3.3% | 0.45% | -4.1% |
| Q2 2014 | $9,841,000 | -2.4% | 124,995 | -7.1% | 0.47% | -17.3% |
| Q1 2014 | $10,087,000 | -6.4% | 134,495 | -3.7% | 0.56% | -4.4% |
| Q4 2013 | $10,779,000 | +7.6% | 139,616 | -3.4% | 0.59% | +2.2% |
| Q3 2013 | $10,015,000 | -3.3% | 144,484 | -11.7% | 0.58% | -4.8% |
| Q2 2013 | $10,359,000 | – | 163,649 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |